HS-20094
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Regeneron · Phase 2 · Recruiting · Enrollment 360
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Olatorepatide arm 1 | n/r | n/r | n/r | n/r | n/r |
| Olatorepatide arm 2 | n/r | n/r | n/r | n/r | n/r |
| Olatorepatide arm 3 | n/r | n/r | n/r | n/r | n/r |
| Olatorepatide arm 4 | n/r | n/r | n/r | n/r | n/r |
| Olatorepatide arm 5 | n/r | n/r | n/r | n/r | n/r |
| Matching Placebo arm 6 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.